Skip to main content

Table 2 Summary of incidence, disease-free survival, and pattern of brain metastasis [32, 33, 37]

From: Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review

Primary Site Incidence Median Disease-Free Interval Only site of metastatic disease Solitary metastasis
Ovarian (n = 521) 1.19 % (413/34 728) 24.3 months (11–46) 46.8 % (236/504) 41.9 % (205/489)
Endometrial (n = 115) 0.59 % (61/10 199) 17 months (2–108) 49 % (48/98) 56.8 % (50/88)
Cervical (n = 100) 0.57 % (n = 65/11 249) 18 months (0.25-105 months) 46.8 % (37/79) 50.6 % (40/79)